Xihuang Pill (西黄丸) induces mesenchymal-epithelial transition and inhibits loss of apical-basal polarity in colorectal cancer cell through regulating ZEB1-SCRIB Loop

Miao Wang; Jing-yan Meng; Su-fei He

doi:10.1007/s11655-014-1812-8

Your Location：

Home >

Browse articles >

Xihuang Pill (西黄丸) induces mesenchymal-epithelial transition and inhibits loss of apical-basal polarity in colorectal cancer cell through regulating ZEB1-SCRIB Loop

Updated：2021-08-27

- Xihuang Pill (西黄丸) induces mesenchymal-epithelial transition and inhibits loss of apical-basal polarity in colorectal cancer cell through regulating ZEB1-SCRIB Loop
- Chinese Journal of Integrative Medicine Vol. 20, Issue 10, Pages: 751-757(2014)
- Affiliations：
  
  1. College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine,Tianjin,China
  2. Scientific Research Department, Tianjin University of Traditional Chinese Medicine,Tianjin,China
- Author bio：
- Funds：
  
  Supported by the National Natural Science Foundation of China (No. 81273636)
- DOI：10.1007/s11655-014-1812-8
  CLC：
- Published：2014，
  
  Published Online：6 May 2014，
Scan for full text
Wang, M., Meng, Jy. & He, Sf. Xihuang Pill (西黄丸) induces mesenchymal-epithelial transition and inhibits loss of apical-basal polarity in colorectal cancer cell through regulating ZEB1-SCRIB Loop., Chin. J. Integr. Med. 20, 751–757 (2014). https://doi.org/10.1007/s11655-014-1812-8

Miao Wang, Jing-yan Meng, Su-fei He. Xihuang Pill (西黄丸) induces mesenchymal-epithelial transition and inhibits loss of apical-basal polarity in colorectal cancer cell through regulating ZEB1-SCRIB Loop. [J]. Chinese Journal of Integrative Medicine 20(10):751-757(2014)
Wang, M., Meng, Jy. & He, Sf. Xihuang Pill (西黄丸) induces mesenchymal-epithelial transition and inhibits loss of apical-basal polarity in colorectal cancer cell through regulating ZEB1-SCRIB Loop., Chin. J. Integr. Med. 20, 751–757 (2014). https://doi.org/10.1007/s11655-014-1812-8 DOI：

Miao Wang, Jing-yan Meng, Su-fei He. Xihuang Pill (西黄丸) induces mesenchymal-epithelial transition and inhibits loss of apical-basal polarity in colorectal cancer cell through regulating ZEB1-SCRIB Loop. [J]. Chinese Journal of Integrative Medicine 20(10):751-757(2014) DOI： 10.1007/s11655-014-1812-8.

摘要

To investigate the antiproliferative and anti-metastasis effect of Xihuang Pill (西黄丸

XP) on human colorectal cancer cell and to explore the molecular mechanism by which it produces the effects. Highly metastatic human colorectal cancer cell line LoVo was treated with low-

medium-

and highdose XP-containing serum (XP-L

XP-M

XP-H) groups for 48 h

cells intervened with no drug rat serum and PD98059 [extracellular signal-regulated kinase (ERK) inhibitor] as negative and positive controls (NC and PC) groups. Cell proliferation assay was made using cell counting kit-8 (CCK8). The 8 μm pore-size transwell chamber and 4′

6-diamidino-2-phenylindole (DAPI) staining were applied to examine the ability of invasion and migration of the cells. The protein expression of ERK1/2

zinc fifi nger E-box-binding homeobox 1 (ZEB1)

Scrib and lethal giant larvae homolog 2 (Lgl2) was detected by Western blotting while the relative mRNA quantity of E-cadherin

N-cadherin

Occludin and junctional adhesion molecule-1 (JAM1) was measured by realtime fluorescent quantitative polymerase chain reaction (RT-qPCR). XP induced a dose-dependent suppression on the proliferation of LoVo cells (P <0.05 or P<0.01)

with the inhibition rates varied from 27.30% to 31.08%. Transwell assay showed that when preprocessed with PD98059 and XP-containing serum

the number of cells that passed the filter decreased significantly compared with that of NC group (P <0.05 or P<0.01). Moreover

XP inhibited the protein expression of ERK1/2 and ZEB1 (P <0.05); and up-regulated the protein expression of Scrib and Lgl2 (P <0.05). The mRNA levels of E-cadherin

Occludin and JAM1 of the XP intervened groups and PC group markedly ascended (P <0.05) while that of N-cadherin showed a descending tendency (P>0.05). XP intervention suppressed the ability of proliferation

invasion and migration of the LoVo cells. Regulating ZEB1-SCRIB Loop so as to recover epithelial phenotype and apical junctional complex might be one of the mechanisms by which XP produces the anti-metastasis effect.

Abstract

To investigate the antiproliferative and anti-metastasis effect of Xihuang Pill (西黄丸

XP) on human colorectal cancer cell and to explore the molecular mechanism by which it produces the effects. Highly metastatic human colorectal cancer cell line LoVo was treated with low-

medium-

and highdose XP-containing serum (XP-L

XP-M

XP-H) groups for 48 h

6-diamidino-2-phenylindole (DAPI) staining were applied to examine the ability of invasion and migration of the cells. The protein expression of ERK1/2

zinc fifi nger E-box-binding homeobox 1 (ZEB1)

Scrib and lethal giant larvae homolog 2 (Lgl2) was detected by Western blotting while the relative mRNA quantity of E-cadherin

N-cadherin

with the inhibition rates varied from 27.30% to 31.08%. Transwell assay showed that when preprocessed with PD98059 and XP-containing serum

the number of cells that passed the filter decreased significantly compared with that of NC group (P <0.05 or P<0.01). Moreover

XP inhibited the protein expression of ERK1/2 and ZEB1 (P <0.05); and up-regulated the protein expression of Scrib and Lgl2 (P <0.05). The mRNA levels of E-cadherin

关键词

Xihuang Pillanti-metastasisepithelial-mesenchymal transitionapical-basal polaritycolorectal cancer

Keywords

Xihuang Pillanti-metastasisepithelial-mesenchymal transitionapical-basal polaritycolorectal cancer

references

Voulgari A, Pintzas A. Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta 2009;1796:75–90.

Moreno-Bueno G, Portillo F, Cano A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 2008;27:6958–6969.

Loboda A, Nebozhyn MV, Watters JW, Buser CA, Shaw PM, Huang PS, et al. EMT is the dominant program in human colon cancer. BMC Med Genomics 2011;4:9.

Etienne-Manneville S. Polarity proteins in migration and invasion. Oncogene 2008;27:6970–6980.

Coradini D, Casarsa C, Oriana S. Epithelial cell polarity and tumorigenesis: new perspectives for cancer detection and treatment. Acta Pharmacol Sin 2011;32:552–564.

Spaderna S, Schmalhofer O, Wahlbuhl M, Dimmler A, Bauer K, Sultan A, et al. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 2008;68:537–544.

Sánchez-Tilló E, Lázaro A, Torrent R, Cuatrecasas M, Vaquero EC, Castells A, et al. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatinremodeling protein BRG1. Oncogene 2010;29:3490–3500.

McCaffrey LM, Macara IG. Epithelial organization, cell polarity and tumorigenesis. Trends Cell Biol 2011;21:727–735.

Shin S, Blenis J. ERK2/Fra1/ZEB pathway induces epithelialto-mesenchymal transition. Cell Cycle 2010;9:2483–2484.

Nagasaka K, Pim D, Massimi P, Thomas M, Tomaic V, Subbaiah VK, et al. The cell polarity regulator hScrib controls ERK activation through a KIM site-dependent interaction. Oncogene 2010;29:5311–5321.

Chen XY, Wang J, Zhang YY, Dong Q. Analysis of antitumor effects of Xihuang Pill based on pharmacodynamic studies review. China J Tradit Chin Med Pharm (Chin) 2010;25:409–412.

Tang ZY. Fighting against cancer by integrative medicine. Chin J Integr Med 2012;18:323–324.

Dobos GJ, Kirsehbaum B, Choi KE. The Western model of integrative oncology-the contribution of Chinese medicine. Chin J Integr Med 2012;18:643–651.

Royer C, Lu X. Epithelial cell polarity: a major gatekeeper against cancer?. Cell Death Differ 2011;18:1470–1477.

Roskoski R Jr. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res 2012;66:105–143.

Kong D, Li Y, Wang Z, Sarkar FH. Cancer stem cells and epithelial-to-mesenchymal transition (EMT)-phenotypic cells: are they cousins or twins?. Cancers 2011;3:716–729.

Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704–715.

Ellenbroek SI, Iden S, Collard JG. Cell polarity proteins and cancer. Semin Cancer Biol 2012;22:208–215.

Knobilich JA. Asymmetric cell division: recent developments and their implications for tumour biology. Nat Rev Mol cell Biol 2010;11:849–860.

Neumüller RA, Knoblich JA. Dividing cellular asymmetry: asymmetric cell division and its implications for stem cells and cancer. Genes Dev 2009;23: 2675–2699.

Martin-Belmonte F, Perez-Moreno M. Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer 2011;12:23–38.

Paterson EL, Kazenwadel J, Bert AG, Khew-Goodall Y, Ruszkiewicz A, Goodall GJ. Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression. Neoplasia 2013;15:180–191.

Kawauchi T. Cell adhesion and its endocytic regulation in cell migration during neural development and cancer metastasis. Int J Mol Sci 2012;13:4564–4590.

Dow LE, Elsum IA, King CL, Kinross KM, Richardson HE, Humbert PO. Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signaling. Oncogene 2008;27:5988–6001.

Chaudhary AK, Pandya S, Ghosh K, Nadkarni A. Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: an overview. Mutat Res 2013;753:7–23.

Sun LN, Meng JY, Wang W, Ying SL, Li D, Ma ZY, et al. Effect of Xihuang pills on protein expressions of MMP-2 and MMP-9 in human colorectal carcinoma LoVo cell. Tianjin J Tradit Chin Med (Chin) 2012;29:378–380.

FULL TEXT LINK

More>

Views

648

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Effects of Jianpi Jiedu Recipe (健脾解毒方) on reversion of P-glycoprotein-mediated multidrug resistance through COX-2 pathway in colorectal cancer

Nodule and eminence on frenulum labii superioris: Diagnostic markers for metastatic colorectal cancer

Yiqi Zhuyu Decoction (益气逐瘀汤) Combined with FOLFOX-4 as first-line therapy in metastatic colorectal cancer

Evolution of the management of colorectal cancer using integrative medicine

Related Author

No data

Related Institution

Department of Nephrology, Zhejiang Provincial Hospital of Integrated Chinese and Western Medicine

Department of Chemistry, University of South Florida

Department of Biomedical Sciences, Cornell University, Ithaca

Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute

Department of Medical Oncology, Shuguang Hospital & Putuo Hospital, Shanghai University of Traditional Chinese Medicine

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰